J Korean Ophthalmol Soc.  2014 Dec;55(12):1868-1877. 10.3341/jkos.2014.55.12.1868.

Research on the Quality of Life of Glaucoma Patients

• Feng CS
• Yi K

• KMID: 2338978
• DOI: http://doi.org/10.3341/jkos.2014.55.12.1868

Abstract

PURPOSE
To compare subjective quality of life (QOL) of a glaucoma group with a control group.
METHODS
The Korean version of the National Eye Institute Visual Function Questionnaire 25 (NEI-VFQ-25) was completed by 105 glaucoma clinic patients including 54 glaucoma group and 56 control group. We compared questionnaire scores and previous performed visual field parameters between a glaucoma group and a control group.
RESULTS
The glaucoma group results were: Mean age: 55.73 +/- 15.17 years; mean best corrected visual acuity (BCVA; log MAR) 0.05 +/- 0.09 in better eyes and 0.06 +/- 0.09 in worse eyes; and mean intraocular pressure (IOP) 15.94 +/- 2.93 mm Hg in better eyes and 15.49 +/- 3.18 mm Hg in worse eyes. Control group scores were: Mean age: 51.85 +/- 11.36 years; mean BCVA (log MAR) 0.04 +/- 0.07 in better eyes and 0.06 +/- 0.08 in worse eyes; and mean IOP 16.40 +/- 2.50 mm Hg in better eyes and 16.13 +/- 2.16 mm Hg in worse eyes. Age, BCVA, and IOP were not significantly different between groups, but visual field index (VFI) score and visual function questionnaire (NEI-VFQ-25) total score were significantly lower in the glaucoma group (p < 0.01). Additionally, visual field parameters and QOL had a significant relationship in the glaucoma group, especially in better eyes.
CONCLUSIONS
The QOL of glaucoma patients was lower than that of normal controls regardless of visual acuity. The degree of visual field loss in the better eye may affect QOL more significantly.

Keyword

Glaucoma patients; Quality of life; Questionnaire

MeSH Terms

Glaucoma*
Humans
Intraocular Pressure
National Eye Institute (U.S.)
Quality of Life*
Surveys and Questionnaires
Visual Acuity
Visual Fields

Figure

• 

  Figure 1. Negative correlation of age and NEI-VFQ-25 questionnaire total scale. (A) Age and total score in glaucoma group (r = −0.279, p < 0.05). (B) Age and total score in control group (r = −0.469, p < 0.01).

• 

  Figure 2. NEI-VFQ-25 questionnaire total scale and visual field index of both eyes in glaucoma group showed significant correlation. (A) Visual field index and total score (r = 0.381, p < 0.01). (B) Mean deviation and total score (r = 0.411, p < 0.01). (C) Pattern standard deviation and total score (r = −0.321, p < 0.05). VFI = visual field index; MD = mean deviation; PSD = pattern standard deviation.

Reference

References

1. Van Buskirk EM, Cioffi GA. Glaucomatous optic neuropathy. Am J Ophthalmol. 1992; 113:447–52.

2. Armaly MF. Ocular pressure and visual fields. A ten-year follow-up study. Arch Ophthalmol. 1969; 81:25–40.

3. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol. 1998; 126:498–505.

4. Levene RZ. Low tension glaucoma: a critical review and new material. Surv Ophthalmol. 1980; 24:621–64.

5. Perkins ES. The Bedford glaucoma survey. I. Long-term follow-up of borderline cases. Br J Ophthalmol. 1973; 57:179–85.

6. Guedes RA, Guedes VM, Freitas SM, Chaoubah A. Quality of life of glaucoma patients under medical therapy with different prostaglandins. Clin Ophthalmol. 2012; 6:1749–53.

7. Hahm BJ, Shin YW, Shim EJ, et al. Depression and the vision-related quality of life in patients with retinitis pigmentosa. Br J Ophthalmol. 2008; 92:650–4.

8. Seo JH, Yu HG, Lee BJ. Assessment of functional vision score and vision-specific quality of life in individuals with retinitis pigmentosa. Korean J Ophthalmol. 2009; 23:164–8.

9. Kim JW, Choi KS, Rhee MR, Lee SJ. Impact of intravitreal bevacizumab injection on life quality in patients with branch retinal vein occlusion. J Korean Ophthalmol Soc. 2012; 53:1465–71.

10. Clemons TE, Chew EY, Bressler SB, McBee W. National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS Report No. 10. Arch Ophthalmol. 2003; 121:211–7.

11. Klein R, Moss SE, Klein BE, et al. The NEI-VFQ-25 in people with long-term type 1 diabetes mellitus: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Ophthalmol. 2001; 119:733–40.

12. Mangione CM, Lee PP, Pitts J, et al. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators. Arch Ophthalmol. 1998; 116:1496–504.

13. Mangione CM, Lee PP, Gutierrez PR, et al. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001; 119:1050–8.

14. Suzukamo Y, Oshika T, Yuzawa M, et al. Psychometric properties of the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25), Japanese version. Health Qual Life Outcomes. 2005; 3:65.

15. Lohr KN, Brook RH, Kamberg CJ, et al. Use of medical care in the Rand Health Insurance Experiment. Diagnosis- and service-specific analyses in a randomized controlled trial. Med Care. 1986; 24(9 Suppl):S1–87.

16. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993; 31:247–63.

17. Heo JW, Yoon HS, Shin JP, et al. A validation and reliability study of the Korean version of national eye institute visual function questionnaire 25. J Korean Ophthalmol Soc. 2010; 51:1354–67.

18. Sawada H, Fukuchi T, Abe H. Evaluation of the relationship between quality of vision and the visual function index in Japanese glaucoma patients. Graefes Arch Clin Exp Ophthalmol. 2011; 249:1721–7.

19. Okamoto M, Sugisaki K, Murata H, et al. Impact of better and worse eye damage on quality of life in advanced glaucoma. Sci Rep. 2014; 4:4144.

20. Qiu M, Wang SY, Singh K, Lin SC. Association between visual field defects and quality of life in the United States. Ophthalmology. 2014; 121:733–40.